Skip to Main Content

Advertisement

Skip Nav Destination

Abstract CT184: Emerging evidence of activity of BLU-945 in patients with advanced EGFR-mutant NSCLC utilizing circulating tumor DNA (ctDNA) in the phase 1/2 SYMPHONY study

Cancer Res (2022) 82 (12_Supplement): CT184.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Kai Fu
  • Fachao Xie
  • Fang Wang
  • Liwu Fu
Journal of Hematology & Oncology (2022) 15 (1)
  • Hong-Yi Zhao
  • Xiao-Xiao Xi
  • Minhang Xin
  • San-Qi Zhang
Bioorganic Chemistry (2022) 128: 106057.
  • Jiyun Lee
  • Zofia Piotrowska
  • Ross Soo
  • Byoung Chul Cho
  • Sun Min Lim
Therapeutic Advances in Medical Oncology (2022) 14: 175883592211440.
Close Modal

or Create an Account

Close Modal
Close Modal